Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1007/s10637-025-01529-4

Bispecific antibody targeting CD155 mediates T-cell immunotherapy against human gynecological malignancies

Li Ma & Xin Xue et al. · 2025-04-15

1Citations

Links

DOI PubMed

Journal

Investigational New Drugs

TL;DR

It is demonstrated that CD155 is a promising target for gynecological tumors, and CD155Bi-T cells hold significant potential for immunotherapy against CD155+ gynecological malignancies.

AI-generated by Semantic Scholar

Authors

Li Ma, Juan Ma, Dingqing Feng, Xin Xue

Funding

the National Natural Science Foundation of China Grant 82273052 R&D Program of Beijing Municipal Education Commission Grant KZ202110025028 the National High-Level Hospital Clinical Research Funding Grant 2024-NHLHCRF-PYI-06, 2024-NHLHCRF-YXHZ-MS-06 Independent Research Project of China Academy of Chinese Medical Sciences Grant No.YZ202117